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ABSTRACT 
Objective: Although changes in pigmentation distribution are known to be a major characteristic of cutaneous ageing in Asian skin, wrinkling was 
also shown to be a main feature of skin ageing in Asians. The role of reactive oxygen species and the decrease in anti-oxidant enzymes activity with 
age was recently confirmed for both intrinsic and extrinsic ageing, making oxidative stress of primary importance in the overall ageing process.  
Polygonum minus is found in local Malaysian herbs known as “kesum”. Previous studies have demonstrated the anti-oxidant properties of kesum as 
a food ingredient or medicinal plant. However, little is known about the in vivo anti-oxidant and resulting anti-wrinkle efficacy of Polygonum minus 
in a cosmetic product. LineminusTM is an extract developed from Polygonum minus leaves (with 3 pending patents: Malaysia PI2012005685, 
Malaysia PI20125248, and Malaysia PI2012003882/ PCT/MY2013/000033). 
The aim of this study was to evaluate the efficacy and safety of LineminusTM cream versus its placebo in healthy Asian females (split-face).  
Methods: Methods used were shadow casting analysis of crow’s feet silicone replicas, self-assessment and dermatological evaluation. Twenty three 
healthy Asian females, aged between 48-60 years old, having wrinkles on the crow’s feet area were enrolled. 
Results: Results showed that application of LineminusTM cream induced a significant decrease in “number of wrinkles” (-17.6% and -20.1%, p<0.05), 
“total length” (-15.9% and -25.7%, p<0.05) after 1 and 2 months and “mean length” after 2 months (-8.6%, p<0.05). When variations from the skin 
treated with Lineminus cream were corrected from the ones of the skin treated with Placebo Cream, there was a statistically significant difference in 
“number of wrinkles” after 1 month (-12.4%, p<0.05) and “mean length” of wrinkles after 2 months (-7.3%, p<0.05). Subjects significantly agreed to 
most questions asked to them about LineminusTM cream’s efficacy after 1 and 2 months. Finally, the tolerance of both creams was found to be very 
good.  
Conclusion: Based on these results it is possible to conclude that LineminusTM Cream is safe and has an anti-wrinkle effect and that LineminusTM 
(Polygonum minus extract) has beneficial cosmetic anti-wrinkle properties. These results also show that in addition to Polygonum minus’s well-
known anti-oxidant efficacy, the plant extract also demonstrates a significant clinical anti-wrinkle effect with clear reduction of crow’s feet wrinkles. 
Keywords: Cream, skin, lineminus, wrinkles, placebo, Polygonum minus, kesum, replicas, testing. 
 
INTRODUCTION 
Although changes in pigmentation distribution (mottled 
pigmentation, pigmentation spots etc.) are known to be a major 
characteristic of cutaneous ageing in Asian skin [1], wrinkling was 
also shown to be a main feature of skin ageing in Asians [1, 2] as well 
as Caucasians [3]. Skin ageing is the result of two different and 
cumulated processes: intrinsic and extrinsic ageing (also known as 
photo-ageing) [3-6]. While intrinsic ageing is natural and mainly due 
to the passage of time (influence of genetic factors, oxidative stress, 
cellular senescence etc.) and its consequences, photo-ageing is 
mainly linked with the detrimental effects of solar exposure on the 
skin (prominent in Asian countries compared to Western countries 
due to their geographical location), although pollution, diet and 
smoking are also contributing factors [4-7]. The role of reactive 
oxygen species (ROS) and the decrease in anti-oxidant enzymes 
activity with age has been described previously [4], but the role of 
ROS has recently been confirmed for both processes of ageing, not 
only intrinsic ageing [4], making oxidative stress of primary 
importance in the overall ageing process [4]. This partly confirms 
the previous conclusions that extrinsic ageing is superimposed on 
intrinsic ageing [4] and that it also accelerates many key aspects of 
intrinsic ageing. The role of anti-oxidants is to neutralize free 
radicals by supplying another electron, delivering an electron pair to 
an oxygen molecule and stabilizing it in the process [3]. The use of 
anti-oxidants to hinder the pathways of collagen breakdown is 
thought to inhibit photo-ageing by preventing collagenase 
production and its detrimental influence on collagen [3]. It appears 
therefore that anti-oxidant properties provided to the skin could act 
as anti-ageing and improve its clinical features such as wrinkles.  
Polygonum minus (also known as Persicaria minor) is found in local 
Malaysian herbs and it is popular with its local name “kesum” [8-11]. 
Previous studies have demonstrated the anti-oxidant properties of 
kesum as a food ingredient or medicinal plant [8-11], with 
sometimes comparing it to other herbs known for their anti-oxidant 
properties [8, 10]. Similar studies were also performed on a wide 
range of other plants from Malaysia, India etc. to assess their anti-
oxidant properties [12, 13]. However, little is known about the in 
vivo anti-oxidant efficacy and resulting anti-wrinkle efficacy of 
Polygonum minus contained in a cosmetic product following topical 
application on the face. LineminusTM is an extract developed from 
Polygonum minus leaves (with 3 pending patents: Malaysia 
PI2012005685, Malaysia PI20125248, and Malaysia PI2012003882 
/ PCT/MY2013/000033). LineminusTM cream contains LineminusTM 
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as its main active ingredient with other ingredients to complete the 
formulation of the cream. 
The present study was performed in order to evaluate the efficacy 
and safety of Lineminus cream as an anti-wrinkle cream in a panel of 
healthy Asian females. 
MATERIALS AND METHODS 
Material and product preparation 
The extract was obtained from a commercial batch of LineminusTM. 
The standardized aqueous extract was prepared by a water 
extraction of Polygonum minus leaves using the high pressure water 
extraction technology (Pending Patent Malaysia PI2012003882 / 
PCT/MY2013/000033) comprising the steps of a) subjecting the 
dried leaves to hot water extraction by percolation; b) filtering; c) 
followed by concentration and by condensation; d) drying without 
any carrier; and e) size reduction, obtaining the dry extract powder. 
The dry extract powder was standardized for content of Quercetin-
3-Glucuronide and Quercitrin. 
The LineminusTM Cream gel was produced under GMP 
manufacturing facility with ingredients such as: Isohexadecane, 
Polyacrylamide & C13-14 Isoparaffin & Laureth-7, Butylene Glycol, 
Cyclopentasiloxane & Cyclotetrasiloxane & Dimethiconol, 
Cyclotetrasiloxane & Cyclopentasiloxane, Lineminus Powder Extract. 
Aim of the study 
The objective of this study was to evaluate the in vivo anti-wrinkle 
efficacy and safety of Lineminus cream versus its placebo cream, 
within the same group of healthy Asian skin type female subjects 
(split-face design). Objective measurements of the skin, 
dermatological evaluation as well as complementary subjective 
evaluation by the subjects were used to demonstrate the efficacy and 
safety of Lineminus cream and to compare it to its placebo cream. 
Study design 
This was a single centric study where all subjects were aware of the 
expected effects of the tested products. However, they were not 
informed which of the two products was the placebo. This was a 
split-face comparative study (Lineminus cream versus placebo) 
where each subject was used as her own control. The study was 
performed in SPINCONTROL ASIA Co., Ltd., Bangkok, Thailand from 
November 21, 2012 until January 23, 2013. This non-interventional 
study was performed according to the most recent 
recommendations given by the World Medical Association (Helsinki 
Statement 1964, amended in Seoul, Korea, 2008). 
Inclusion criteria 
Twenty three healthy Asian skin type female subjects, aged between 
48 and 60 years old, having wrinkles on both crow’s feet areas with 
a grade ≥ 3 according to the “Skin Ageing Atlas” (corresponding to 
moderate to severe wrinkles) [14], without any skin hypersensitivity 
or known allergy to cosmetic products, were enrolled in this study. 
All the subjects gave their informed written consent before 
beginning the study. 
Exclusion criteria 
Subjects were not allowed to take part in the study if they were 
pregnant or breastfeeding a child at the time of enrollment or if they 
had stopped breastfeeding within the past 3 months. Subjects with 
existing cutaneous or general disease and subjects following any 
chronic or intermittent medicinal treatment were not included in the 
study. Subjects having made injections of anti-wrinkle products or 
having undergone techniques with aesthetic aim in the past year as 
well as having applied products with an anti-wrinkle action 
(Retinoic acid, retinol, retinaldehyde, A.H.A etc.) in the 2 weeks 
preceding the start of the study were also not included. 
Study restrictions 
At the baseline visit, subjects were asked to respect a list of 
restrictions throughout the 2-month study in order to confirm their 
inclusion. These restrictions were related to the non-use of other 
cosmetic products or aesthetic procedures as well as medication that 
could interfere with the study and impact on the results. This also 
included sun and UV light exposure which should not have been 
intentional and prolonged.  
Study procedures 
Wrinkle evaluation was performed using skin rubber replicas (Silflo, 
Flexico Developments Ltd., UK) of the crow’s feet area followed by 
shadow casting analysis (Fig. 1) with the Quantirides® system (Fig. 
2) and associated software (Courage & Khazaka, Germany). The 
replica, which represents a negative imprint of the skin, is 
illuminated uniformly with a defined white light mounted at a 
specific angle (35°). The shadows visible on the replica created by 
the oblique light are captured with a high resolution camera, which 
is mounted vertically to the replica. The principle of the shadow 
casting analysis comes from the geometrical relationship between 
the depth, width and length of one wrinkle and the surface of the 
shadow it generates when illuminated by an oblique lighting. 
 
Fig. 1: Principle of the shadow casting method 
 
Fig. 2: Quantirides® system 
The crow’s feet area was previously found to be the major site of 
wrinkles in Asian skin [15] and skin replicas analysis, which is 
commonly used in anti-wrinkle studies, was previously taken as the 
method to study changes in skin micro-relief and wrinkles with 
increasing age [16]. It seemed therefore relevant to assess wrinkles 
of the crow’s feet area for this study. Parameters such as number, 
length and depth of wrinkles were analyzed. This method was 
associated with subjective evaluation from the subjects who were 
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asked to answer self-assessment questionnaires following products 
application. A set of 13 questions was asked to subjects after 1 and 2 
months of products application for each treated half-face. Seven 
questions were related to the evaluation of product efficacy (anti-
wrinkle, anti-ageing, improvement of eye contour appearance) while 
the remaining six questions focused on product cosmetic 
acceptability (ease to spread, appreciation of the fragrance etc.). For 
each question, subjects had the option to choose one of the four 
possible answers: totally agree, rather agree, rather disagree and 
totally disagree.  
Finally, dermatological evaluation of skin tolerance was performed 
by a dermatologist in order to ensure that there was no change in 
the subjects’ skin quality following application of the test products. 
This evaluation was based on visual evaluation (objective attributes 
such as erythema, edema and scaling) as well as an interview of the 
subjects to report functional signs (subjective attributes such as 
stinging, itching, sensation of warmth etc.). When a sign was 
observed by the dermatologist or reported by the subject, it was 
graded by the dermatologist using a 5-point scoring system, from 0 = 
absent/no evident reaction to 4 = extreme reaction. An overall 
tolerance conclusion (for each subject as well as for the whole panel) 
was made by the dermatologist at the end of the study, based on the 
evaluations made throughout the study as well as spontaneous 
reporting of undesirable events by the subjects. This overall 
conclusion by the dermatologist was made using a 4-point scoring 
system, from 1 = poor tolerance to 4 = very good tolerance. All 
measurements and evaluations were performed at baseline (except 
self-assessment), after 1 and after 2 months of products application. 
Ambient conditions were monitored for each visit (acceptable range 
of 20-24°C and 40-60% relative humidity) to ensure that there 
would be no effect of these factors on measurements and 
evaluations. 
Primary and secondary outcome measurements and evaluation 
The primary techniques used were skin rubber replicas followed by 
analysis with shadow casting method and self-assessment using 
questionnaires. The second outcome evaluation was dermatological 
control of skin tolerance which was based on objective (evaluation 
by the dermatologist) and subjective evaluation (feedback from 
subjects). 
Adverse events 
The reporting of any adverse event by the subjects themselves, the 
dermatologist or the technicians taking part in the study was done 
using an adverse event report form. The type of sign, its intensity, 
duration, evolution and decision made by the investigator regarding 
the subject’s participation in the study were collected and fed back 
to the study sponsor. Finally, the investigator defined the 
relationship between the observed sign and the tested product 
(unlikely, possible, certain or un-assessable). Subject follow-up was 
also implemented depending on the type and intensity of sign 
observed as well as whether the subject had to be withdrawn from 
the study following appearance of the undesirable event. 
Statistical analysis 
Data from subjects who successfully completed the whole study with 
attendance to all three visits was exploited for the analysis. Data 
from any subject withdrawn from the study was removed from the 
final results, except if this withdrawal was linked with an adverse 
event, in which case data from this subject was kept into results 
from dermatological evaluation.  
 
Comparison in time for each product was done using the Shapiro-
Wilk test (significance threshold: 1%) to check the normality of the 
distributions, followed by the Student t-test (normality of 
distributions checked) or by the Wilcoxon test (normality of the 
distributions rejected) to analyze the evolution of the measured 
parameters during the study for each product. The significance 
threshold of both tests was 5%. 
Comparison between the two products at T0 and at Tn-T0 was done 
using Shapiro-Wilk test (threshold: 1%). Statistical comparison of 
the two products at T0 and on the differences (Tn-T0), for each of 
the measured parameters, was performed with the Student test 
(normality of distributions checked) or the Wilcoxon test (normality 
of the distributions rejected). The significance threshold was set to 
5%. 
The analysis of self-assessment questionnaires involved establishing 
frequency tables that took into account the number of responses and 
calculated the frequency of the different possible answers (given as a 
percentage) to each qualitative question. For each question, results 
were shown in tabular form (number of individuals and frequency). 
Answers to self-assessment questionnaires were combined into two 
percentages: a percentage representing favorable opinion 
(combining “Totally agree” and “Rather agree” answers) and a 
percentage representing unfavorable opinion (combining “Totally 
disagree” and “Rather disagree”). The statistical difference in 
frequencies (percentages) between favorable and unfavorable 
opinions was analyzed using the Chi-squared test (significance level 
set to 5%). 
Results from dermatological evaluation were compiled into grades, 
from 1 = poor tolerance to 4 = very good tolerance. This data was 
therefore not analyzed using any statistical analysis. 
RESULTS 
Study population 
One subject was absent and another subject withdrew herself from 
the study at the last visit (T+2 months) because of personal reasons, 
therefore these were not related to the tested products. Crow’s feet 
replica from this latter subject could not be exploited for the analysis 
with shadow casting method. Therefore twenty one subjects 
successfully completed the study. The recruited panel at baseline 
was aged between 48 and 60 years old (mean age: 54.0 years old). 
Products safety evaluation 
None of the subjects from this study, dermatologist or technicians 
reported any adverse event during the 2-month study, for both 
treated half-faces.  
No functional or clinical sign was observed for none of the subjects 
on each half-face, at none of the study kinetics namely baseline, after 
1 and after 2 months of products application (Table 1). 
Therefore the dermatologist who made the evaluations concluded 
that the skin tolerance of subjects participating in this study was 
very good for LINEMINUS CREAM as well as for the PLACEBO 
CREAM after twice daily application on one half-face during 2 
months (Table 2). 
 
Table 1: Mean results (±SD) of dermatological scoring (functional and clinical signs) on the subjects’ face for each test product at baseline, 
after 1 and 2 months of products usage (4-level system with 0 = Absent/ No evidence reaction, 1 = Slight, 2 = Moderate, 3 = Severe and 4 = 
Extreme reaction) 
 Functional signs Clinical signs 
 LINEMINUS CREAM PLACEBO CREAM LINEMINUS CREAM PLACEBO CREAM 
Kinetics Mean S.D. Mean S.D. Mean S.D. Mean S.D. 
Baseline 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
T+1 month 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
T+2 months 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
Variation after 1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
Blanche et al. 




Variation after 2 
months 
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
 
Table 2: Mean results (±SD) of skin tolerance determined after 
2 months of products usage for each test product, based on the 
individual scores of skin tolerance given by the dermatologist 
(1 = Poor tolerance, 2 = Medium tolerance, 3 = Good tolerance 
and 4 = Very good tolerance) 
Product Overall skin tolerance after 2 months 
(Mean ± S.D.) 
LINEMINUS CREAM 4.0 ± 0.0 
PLACEBO CREAM 4.0 ± 0.0 
Products efficacy evaluation 
Results from replicas analysis with the shadow casting method 
showed that application of LINEMINUS CREAM (Table 3) induced a 
decrease in all measured parameters after 1 and 2 months of 
application when compared to baseline values, except for the mean 
depth of wrinkles after 1 month of treatment. These decreases 
reached statistical significance for the parameters “number of 
wrinkles” after 1 month (-17.6%, p<0.05) and 2 months (-20.1%, 
p<0.05), “total length” after 1 month (-15.9%, p<0.05) and 2 months 
(-25.7%, p<0.05) and “mean length” after 2 months only (-8.6%, 
p<0.05). These results show that the anti-wrinkle efficacy of 
LINEMINUS CREAM progressively increased between 1 and 2 
months of treatment, as seen by higher percentages of reduction of 
wrinkle number and length. It should be noted that the slight 
increase in the “mean depth” parameter is believed to be due to the 
fact that the product acted primarily on the fine lines. In this case, at 
the end of the 2-month treatment only bigger wrinkles remained, 
and this contributed more to the mean parameters such as mean 
depth. 
Results from replicas analysis with the shadow casting method 
showed that application of the PLACEBO CREAM (Table 4) induced a 
reduction in all assessed parameters after 1 and 2 months of product 
application, however, the only variation which reached statistical 
significance was “number of wrinkles” after 2 months only (-15.8%, 
p<0.05). The slight decrease in all assessed parameters is believed to 
be linked with the moisturizing efficacy of the placebo formula 
which helped improving fine lines through an effect on the skin 
micro-relief. 
 
Table 3: Mean results of parameters from silicone replicas analysis with shadow casting for the whole panel at baseline, after 1 and 2 
months of LINEMINUS CREAM usage and variations (% and p value) compared to baseline after 1 and 2 months 
 LINEMINUS CREAM 
Kinetic Number of wrinkles Total wrinkle area 
(mm2) 
Total length (mm) Mean length (mm) Mean depth 
(µm) 
Baseline 88.0 21.1 87.2 1.0 113.2 
T+1 month 72.6 17.2 73.3 1.0 119.4 
T+2 months 70.4 16.9 64.7 0.9 112.8 

















Table 4: Mean results of parameters from silicone replicas analysis with shadow casting for the whole panel at baseline, after 1 and 2 
months of PLACEBO CREAM usage and variations (% and p value) compared to baseline after 1 and 2 months 
 PLACEBO CREAM 
Kinetic Number of wrinkles Total wrinkle area 
(mm2) 
Total length (mm) Mean length (mm) Mean depth (µm) 
Baseline 80.6 19.3 78.6 0.9 114.5 
T+1 month 76.5 16.3 75.9 0.9 109.3 
T+2 months 67.9 15.7 67.1 0.9 114.0 










Variation after 2 
months 









Table 5: Mean variations (expressed in percentage and with p value) of parameters from silicone replicas for LINEMINUS CREAM 
corrected from the variations observed on the skin treated with PLACEBO CREAM for 1 and 2 months 
Variations Number of 
wrinkles 
Total wrinkle area 
(mm2) 
Total length (mm) Mean length (mm) Mean depth (µm) 



















When variations of wrinkle parameters from shadow casting 
method on the skin treated with LINEMINUS CREAM were corrected 
from the variations observed on the skin treated with PLACEBO 
CREAM (Table 5), results show that there was a decrease in all 
measured parameters after 1 and 2 months of product usage, except 
for the mean depth of wrinkles. As mentioned previously, the 
increase in mean depth is believed to be linked with the primary 
efficacy of the LINEMINUS CREAM on fine lines before deeper 
wrinkles. The decrease in two measured parameters reached 
statistical significance, namely “number of wrinkles” after 1 month (- 
 
12.4%, p<0.05) and “mean length” of wrinkles after 2 months of 
product application (-7.3%, p<0.05). Since these results represent 
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the efficacy of LINEMINUS CREAM corrected from the efficacy of 
PLACEBO CREAM, they evidence the anti-wrinkle effect of 
Polygonum minus (main ingredient of LINEMINUS CREAM) on crow’s 
feet fine lines and wrinkles. 
Figure 3 shows photographs of skin replicas of the crow’s feet area 
taken before and after application (1 and 2 months) of LINEMINUS 
CREAM for one subject who displayed improvements of crow’s feet 
wrinkles similar to the average improvements (A, B and C). Parts 
highlighted in green on the bottom photographs (D, E and F) 
represent the shadow created by the Quantirides equipment on the 
replicas. 
 
Fig. 3: Photos of skin replicas before (A, top left photograph) 
and after treatment with LINEMINUS CREAM for 1 (B, top 
middle photograph) and 2 months(C, top right photograph) (D, 
E and F represent the photographs with analyzed shadow) 
Results from self-assessment using questionnaire showed that 8 out 
of the 13 items asked to subjects were significantly agreed by the 
panel after 1 month of application of LINEMINUS CREAM and 11 out 
of 13 items were significantly agreed after 2 months of product 
application (Table 6). 
The highest percentages of agreement obtained after 1 month were 
related to the moisturizing effect (87% of agreement) and 
smoothing effect (83% of agreement) of LINEMINUS CREAM on the 
eye contour. These percentages increased after 2 months of product 
usage (90% of agreement obtained for both items), and subjects also 
noticed an improvement of the fine lines on their eye contour (90% 
of agreement). Regarding cosmetic acceptability, subjects found that 
the product was easy to spread and that it did not leave any sticky or 
oily feeling on the skin (91% of agreement obtained for the 3 items). 
These properties were also confirmed (significance threshold 
reached) after 2 months of product usage as well as an easy 
absorption of the product into the skin (90% of agreement). 
Results from self-assessment using questionnaire showed that 8 out 
of the 13 items asked to subjects were significantly agreed by the 
panel after 1 month of application of PLACEBO CREAM and 11 out of 
13 items were significantly agreed after 2 months of product 
application (Table 7). 
 
Table 6: Mean results (percentage of positive opinions) from self-assessment of product efficacy and cosmetic acceptability after 1 and 2 
months of application of LINEMINUS CREAM (p (Chi-2) value to confirm statistical significance, n=23 after 1 month and 21 after 2 months) 
 AFTER 1 MONTH AFTER 2 MONTHS 
EFFICACY AND COSMETIC ACCEPTABILITY OF LINEMINUS CREAM %Positive opinion p(Chi-2) %Positive 
opinion 
p(Chi-2) 
With this product, eye contours seem more moisturized 87% 3.93E-04 90% 2.08E-04 
With this product, fine lines around the eye contours seem diminished 70% 6.06E-02 90% 2.08E-04 
With this product, deep wrinkles around the eye contours seem diminished 52% 8.35E-01 76% 1.64E-02 
With this product, eye contours seem smoother 83% 1.76E-03 90% 2.08E-04 
With this product, eye contours seem tighter 74% 2.18E-02 86% 1.06E-03 
With this product, eye contours seem younger 52% 8.35E-01 67% 1.27E-01 
With this product, your skin around the eye contour had a youthful appearance 61% 2.97E-01 76% 1.64E-02 
This product is easy to spread 91% 7.44E-05 100% 4.59E-06 
This product absorbs easily to the skin 74% 2.18E-02 90% 2.08E-04 
This product has a pleasant fragrance 61% 2.97E-01 67% 1.27E-01 
This product does not leave sticky feeling on the skin 91% 7.44E-05 86% 1.06E-03 
This product does not leave oily residue on the skin 91% 7.44E-05 95% 3.38E-05 
The product gives a pleasant feeling of freshness at application 74% 2.18E-02 71% 4.95E-02 
 
Table 7: Mean results (percentage of positive opinions) from self-assessment of product efficacy and cosmetic acceptability after 1 and 2 
months of application of PLACEBO CREAM (p (Chi-2) value to confirm statistical significance, n=23 after 1 month and 21 after 2 months) 
 AFTER 1 MONTH AFTER 2 MONTHS 
EFFICACY AND COSMETIC ACCEPTABILITY OF PLACEBO CREAM %Positive opinion p(Chi-2) %Positive 
opinion 
p(Chi-2) 
With this product, eye contours seem more moisturized 87% 3.93E-04 90% 2.08E-04 
With this product, fine lines around the eye contours seem diminished 70% 6.06E-02 90% 2.08E-04 
With this product, deep wrinkles around the eye contours seem diminished 52% 8.35E-01 67% 1.27E-01 
With this product, eye contours seem smoother 87% 3.93E-04 90% 2.08E-04 
With this product, eye contours seem tighter 74% 2.18E-02 86% 1.06E-03 
With this product, eye contours seem younger 48% 8.35E-01 62% 2.75E-01 
With this product, your skin around the eye contour had a youthful appearance 43% 5.32E-01 57% 5.13E-01 
This product is easy to spread 91% 7.44E-05 95% 3.38E-05 
This product absorbs easily to the skin 74% 2.18E-02 95% 3.38E-05 
This product has a pleasant fragrance 65% 1.44E-01 67% 1.27E-01 
This product does not leave sticky feeling on the skin 96% 1.19E-05 86% 1.06E-03 
This product does not leave oily residue on the skin 96% 1.19E-05 95% 3.38E-05 
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The highest percentages of agreement obtained after 1 month were 
related to the moisturizing effect (87% of agreement) and 
smoothing effect (87% of agreement) of PLACEBO CREAM on the 
eye contour. These percentages increased after 2 months of product 
usage (90% of agreement for both items), and subjects also noticed  
an improvement of the fine lines on their eye contour (90% of 
agreement). Regarding cosmetic acceptability, subjects found that 
the product was easy to spread and that it did not leave any sticky or 
oily feeling on the skin (91% of agreement obtained for the first item 
and 96% for the following two). These properties were also 
confirmed (significance threshold reached) after 2 months of 
product usage as well as an easy absorption of the product into the 
skin (95% of agreement). 
Products performance comparison  
Comparison of results from shadow casting analysis of crow’s feet 
silicone replicas (Table 8) made at baseline (T0) for both sides of the 
face did not show any significant difference for none of the 
measured parameters. This means that the crow’s feet area of all 
subjects at baseline was not found to be significantly different 
between each side of the face, making the comparison between 
products after treatment possible and without any correction 
required.  
There was a statistically significant difference between LINEMINUS 
CREAM and PLACEBO CREAM in favor of LINEMINUS CREAM in 
terms of decrease of the number of wrinkles after 1 month of 
product application (-15.5 ± 22.4 versus -4.2 ± 22.1, p=4.54E-02). 
There was also a statistically significant difference between 
LINEMINUS CREAM and PLACEBO CREAM in favor of LINEMINUS 
CREAM in terms of decrease of the mean depth of wrinkles after 2 
months of product application (-0.1 ± 0.1 versus 0.0 ± 0.1, p=3.52E-
02). 
 
Subjects were not able to notice more visible anti-ageing effects from 
the LINEMINUS CREAM compared to the PLACEBO CREAM after 1 
month of usage (Table 9). However, they significantly agreed that 
their skin treated with LINEMINUS CREAM had a more youthful 
appearance on the eye contour (76% of agreement, p=1.64E-02) and 
that deep wrinkles around the eye contours seemed diminished 
when treated with LINEMINUS CREAM (76% of agreement, p=1.64E-
02)) for 2 months (Table 10). They did not significantly agree with 
these statements after 2 months of application of PLACEBO CREAM, 
which confirms LINEMINUS CREAM’s long term visible effect on 
crow’s feet wrinkles. 
DISCUSSION  
It was previously shown that phenolic compounds were the main 
contributor of antioxidant activity in plants [10] and that Polygonum 
minus had the highest total phenolic content and reducing power, 
when compared to other herbs and spices such as ginger, turmeric, 
curry leaves etc. [8, 10]. Polygonum minus was also suggested to be a 
potential source of natural antioxidants with similar characteristics 
to the synthetic antioxidant butylated hydroxyanisole (BHT) [8]. 
LineminusTM is an extract developed from Polygonum minus leaves 
with 3 pending patents. The interest of this study was to assess, for 
the first time, the effects of Polygonum minus, contained in a 
cosmetic product, in Asian subjects.  
 
Table 8: Mean values (±SD) of parameters from silicone replicas for the skin treated with LINEMINUS CREAM and the skin treated with 
PLACEBO CREAM for 1 and 2 months. P value to confirm statistical difference between the two products 
  Number of 
wrinkles 
Total wrinkle area Total length Mean length Mean depth 
  Mean ± 
S.D. 
p-value Mean ± 
S.D. 
p-value Mean ± 
S.D. 
p-value Mean ± 
S.D. 



























































16.3 ± 9.5 75.9 ± 
45.3 


















































0.0 ± 0.2 6.31E-
01 












































0.0 ± 0.1 -0.5 ± 
18.1 
  
Table 9: Mean results (percentage of positive opinions) from self-assessment of product efficacy and cosmetic acceptability after 1 month 
of LINEMINUS CREAM and PLACEBO CREAM usage (p (Chi-2) value to confirm statistical significance) 
 LINEMINUS CREAM PLACEBO CREAM 
EFFICACY AND COSMETIC ACCEPTABILITY OF THE PRODUCT %Positive opinion p(Chi-2) %Positive 
opinion 
p(Chi-2) 
With this product, eye contours seem more moisturized 87% 3.93E-04 87% 3.93E-04 
With this product, fine lines around the eye contours seem diminished 70% 6.06E-02 70% 6.06E-02 
With this product, deep wrinkles around the eye contours seem diminished 52% 8.35E-01 52% 8.35E-01 
With this product, eye contours seem smoother 83% 1.76E-03 87% 3.93E-04 
With this product, eye contours seem tighter 74% 2.18E-02 74% 2.18E-02 
With this product, eye contours seem younger 52% 8.35E-01 48% 8.35E-01 
With this product, your skin around the eye contour had a youthful appearance 61% 2.97E-01 43% 5.32E-01 
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This product is easy to spread 91% 7.44E-05 91% 7.44E-05 
This product absorbs easily to the skin 74% 2.18E-02 74% 2.18E-02 
This product has a pleasant fragrance 61% 2.97E-01 65% 1.44E-01 
This product does not leave sticky feeling on the skin 91% 7.44E-05 96% 1.19E-05 
This product does not leave oily residue on the skin 91% 7.44E-05 96% 1.19E-05 
The product gives a pleasant feeling of freshness at application 74% 2.18E-02 74% 2.18E-02 
 
Table 10: Mean results (percentage of positive opinion) from self-assessment of product efficacy and cosmetic acceptability after 2 
months of LINEMINUS CREAM and PLACEBO CREAM usage (p (Chi-2) value to confirm statistical significance) 
 LINEMINUS CREAM PLACEBO CREAM 
EFFICACY AND COSMETIC ACCEPTABILITY OF THE PRODUCT %Positive opinion p(Chi-2) %Positive 
opinion 
p(Chi-2) 
With this product, eye contours seem more moisturized 90% 2.08E-04 90% 2.08E-04 
With this product, fine lines around the eye contours seem diminished 90% 2.08E-04 90% 2.08E-04 
With this product, deep wrinkles around the eye contours seem diminished 76% 1.64E-02 67% 1.27E-01 
With this product, eye contours seem smoother 90% 2.08E-04 90% 2.08E-04 
With this product, eye contours seem tighter 86% 1.06E-03 86% 1.06E-03 
With this product, eye contours seem younger 67% 1.27E-01 62% 2.75E-01 
With this product, your skin around the eye contour had a youthful appearance 76% 1.64E-02 57% 5.13E-01 
This product is easy to spread 100% 4.59E-06 95% 3.38E-05 
This product absorbs easily to the skin 90% 2.08E-04 95% 3.38E-05 
This product has a pleasant fragrance 67% 1.27E-01 67% 1.27E-01 
This product does not leave sticky feeling on the skin 86% 1.06E-03 86% 1.06E-03 
This product does not leave oily residue on the skin 95% 3.38E-05 95% 3.38E-05 
The product gives a pleasant feeling of freshness at application 71% 4.95E-02 76% 1.64E-02 
 
CONCLUSION  
Based on the results from this clinical study it is possible to conclude 
that LineminusTM Cream, containing extracts from plants which are 
common in Asia, is safe and has an anti-wrinkle effect. The results 
also show that LineminusTM (Polygonum minus extract) has 
beneficial cosmetic anti-wrinkle properties which were not only 
confirmed by objective evaluation (analysis of silicone replicas) but 
they were also observed by the subjects after 2 months of daily 
application. These results also show that in addition to Polygonum 
minus’s well-known anti-oxidant efficacy, the plant extract 
demonstrates as well a significant clinical anti-wrinkle effect with 
clear reduction of crow’s feet wrinkles. 
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